Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Harari

Showing results (21-30 of 305) with videos related to

Pageof 31
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 20, 2006
Clinical advancement of EGFR inhibitors in cancer therapyPrakash Chinnaiyan, Paul M Harari
Journal of the American Academy of Dermatology|July 25, 2000
Psoriasis remission time at the Dead SeaD J Abels, M Harari
Seminars in Radiation Oncology|August 14, 2002
Epidermal growth factor receptor modulation of radiation response: preclinical and clinical developmentPaul M Harari, Shyh-Min Huang
Seminars in Radiation Oncology|October 26, 2001
Radiation response modification following molecular inhibition of epidermal growth factor receptor signalingP M Harari, S M Huang
Pediatric Neurology|September 1, 1996
Prognostic clues and outcome of early treatment of nonketotic hyperglycinemiaA Boneh, Y Degani, M Harari
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Combining EGFR inhibitors with radiation or chemotherapy: will preclinical studies predict clinical results?Paul M Harari, Shyh-Min Huang
Oral Oncology|October 19, 2013
Is radiation dose reduction the right answer for HPV-positive head and neck cancer?Randall J Kimple, Paul M Harari
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2014
Interaction of radiation therapy with molecular targeted agentsZachary S Morris, Paul M Harari
International Journal of Radiation Oncology, Biology, Physics|February 28, 2018
When Disaster Strikes: Mitigating the Adverse Impact on Head and Neck Cancer PatientsSue S Yom, Paul M Harari
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Searching for reliable epidermal growth factor receptor response predictors: commentary re M. K. Nyati et al., Radiosensitization by pan-ErbB inhibitor CI-1033 in vitro and in vivo. Clin. Cancer Res., 10: 691-700, 2004Paul M Harari, Shyh-Min Huang
Pageof 31

Showing results (21-30 of 305) with videos related to

Sort By:
Pageof 31
Methods in Molecular Biology (Clifton, N.J.)|June 20, 2006
Clinical advancement of EGFR inhibitors in cancer therapyPrakash Chinnaiyan, Paul M Harari
Journal of the American Academy of Dermatology|July 25, 2000
Psoriasis remission time at the Dead SeaD J Abels, M Harari
Seminars in Radiation Oncology|August 14, 2002
Epidermal growth factor receptor modulation of radiation response: preclinical and clinical developmentPaul M Harari, Shyh-Min Huang
Seminars in Radiation Oncology|October 26, 2001
Radiation response modification following molecular inhibition of epidermal growth factor receptor signalingP M Harari, S M Huang
Pediatric Neurology|September 1, 1996
Prognostic clues and outcome of early treatment of nonketotic hyperglycinemiaA Boneh, Y Degani, M Harari
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Combining EGFR inhibitors with radiation or chemotherapy: will preclinical studies predict clinical results?Paul M Harari, Shyh-Min Huang
Oral Oncology|October 19, 2013
Is radiation dose reduction the right answer for HPV-positive head and neck cancer?Randall J Kimple, Paul M Harari
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2014
Interaction of radiation therapy with molecular targeted agentsZachary S Morris, Paul M Harari
International Journal of Radiation Oncology, Biology, Physics|February 28, 2018
When Disaster Strikes: Mitigating the Adverse Impact on Head and Neck Cancer PatientsSue S Yom, Paul M Harari
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Searching for reliable epidermal growth factor receptor response predictors: commentary re M. K. Nyati et al., Radiosensitization by pan-ErbB inhibitor CI-1033 in vitro and in vivo. Clin. Cancer Res., 10: 691-700, 2004Paul M Harari, Shyh-Min Huang
Pageof 31